Rhythm Pharmaceuticals, Inc. RYTM Total debt

Total debt at other companies

Eli LillyLLY

$54.91B+37.6%

Aardvark Therapeutics, Inc.AARD

$336K-53.7%

Viking TherapeuticsVKTX

$137K-87.8%

Mirum Pharmaceuticals, Inc.MIRM

$12.87M+29.2%

TG TherapeuticsTGTX

$754.44M+197%

Neurocrine BiosciencesNBIX

$463.5M-6.0%

FAQ

What is Rhythm Pharmaceuticals, Inc.'s total debt?

Rhythm Pharmaceuticals, Inc. (RYTM) reported total debt of $112.31M in Q1 2026.

How has Rhythm Pharmaceuticals, Inc.'s total debt changed year-over-year?

Rhythm Pharmaceuticals, Inc.'s total debt decreased by 1.1% year-over-year, from $113.59M to $112.31M.

What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s total debt?

Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s total debt has grown at a 81.9% compound annual growth rate (CAGR), from $5.64M to $112.17M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.